AER20 Planning Committees

AER20 Logo

Core Conference Planning Committee

Co-Chairs:

Albert J. Allen, MD, PhD, Senior Medical Fellow, Pediatric Capabilities, Global Medical Policy Strategy and Operations, Medicines Development Unit, Eli Lilly and Company
Elizabeth A. Buchanan, PhD, Endowed Chair in Ethics, University of Wisconsin Stout

Members:

Melissa Abraham, MS, PhD, Director, Research Ethics Consultation Unit, Division of Clinical Research, Massachusetts General Hospital/Harvard Medical School Center for Bioethics/Ariadne Labs
Captain Richardae Araojo, PharmD, Associate Commissioner for Minority Health; Director of the Office of Minority Health and Health Equity, Office of the Commissioner, Food and Drug Administration
John R. Baumann, PhD, Associate Vice President for Research Compliance, Office of Research Compliance, Indiana University
Brenda L. Curtis, PhD, MSPH, Clinical Investigator; Chief, Technology and Translational Science Section, NIH
Neal W. Dickert Jr., MD, PhD, Assistant Professor, Division of Cardiology, School of Medicine; Assistant Professor, Department of Epidemiology, Rollins School of Public Health, Emory University
Nancy M. P. King, JD, Professor of Social Sciences & Health Policy, Wake Forest School of Medicine
Ivor A. Pritchard, PhD, Senior Advisor to the Director, OHRP
Benjamin Silverman, MD, IRB Chair, Partners Human Research Committee, Partners Healthcare System
Julie Slayton, JD, Director, Office for the Protection of Research Subjects; Professor of Clinical Education, University of Southern California
Sarah White, MPH, Executive Director, Multi-Regional Clinical Trials Center at Brigham and Women's Hospital and Harvard

Workshop/Didactic Subcommittee

Co-Chairs:

Michelle M. Feige, MSW, LCSW-C, Executive Vice President, AAHRPP, Inc.
Megan Kasimatis Singleton, CIP, JD, MBE, Assistant Dean, Human Research Protection; Director, HRPP, Johns Hopkins University School of Medicine

Members:

Amy Ben‑Arieh, Director of Research Compliance, the Fenway Institute
Quincy J. Byrdsong, EdD, CIM, CIP, CCRP, Executive Director of Research Administration, WellStar Health
Karla Childers, MSJ, Senior Director, Strategic Projects, Office of the Chief Medical Officer, Johnson & Johnson
Nichelle Cobb, PhD, Director, Health Sciences IRBs Office, University of Wisconsin-Madison
Janet C. Donnelly, RAC, CIP, Policy Analyst, Office of Good Clinical Practice, Food and Drug Administration
Andrew Hedrick, CIP, MPA, Senior IRB Protocol Analyst, The Ohio State University
Kate Gallin Heffernan, JD, Partner; Chair, Academic and Clinical Research Group, Verrill Dana LLP
John Horigan, CIP, MA, Director of Human Research Protection Program, Virginia Commonwealth University
R. Peter Iafrate, PharmD, IRB-01 Chair; Assistant Director, Research Programs and Services; IRB Chairman, University of Florida
Yvonne Lau, MBBS, MBHL, PhD, Director, Division of Education and Development, OHRP
Andrea McDowell, IRB Administrator, Seattle University
Sara Meeder, CIP, Director, Institutional Review Board, Maimonides Medical Center
Kenia Viamonte, Associate Director, Compliance and IRB Affairs, University of Miami

Poster Abstract Subcommittee

Co-Chairs:

Emily E. Anderson, PhD, MPH, Assistant Professor of Bioethics, Loyola University Chicago
Warren Capell, MD, Clinician-Scientist CPC Clinical Research; Associate Professor of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado at Denver

Members:

Kristina C. Borror, PhD, Director of Policy and Education, Office of Research Oversight, Veterans Health Administration
Stephanie Solomon Cargill, PhD, Assistant Professor, Center for Health Care Ethics, Saint Louis University
Stacy Chandna, MS, CIP, Director, Human Research Protection Program, Connecticut Children’s Medical Center
Liza Dawson, PhD, Chief of Bioethics, Chair of IRB, Walter Reed Army Institute of Research
Sarah Fowler-Dixon, PhD, CIP, Education Specialist, Clinical Research Management and Research Ethics; Instructor, Washington University in St. Louis
Ran Goldman, MD, Professor, Department of Pediatrics, University of British Columbia, BC Children's Hospital
Jan Hewett, BSN, JD, Regulatory Counsel, Policy, Office of Scientific Investigations, Center for Drug Evaluation and Research, FDA
Le’Quan Jackson, CIP, IRB Administrator, Kaiser Permanente Northern California
Sana Khoury-Shakour, PhD, Director, Office of Research Compliance Review, University of Michigan
Hallie Kassan, MS, CIP, Director, Office of the HRPP, Northwell Health
Michael Linke, PhD, CIP, IRB Chair; Associate Professor, University of Cincinnati College of Medicine; Health Science Officer, Cincinnati VA Medical Center; Chair, Central IRB, StrokeNet, NIH
Hiromi Martorano, PhD, CIP, IRB Program Manager, SCL Health
Lindsay McNair, MD, MPH, MSB, Chief Medical Officer, WIRB-Copernicus Group
Casey Mumaw, CIP, MA, Assistant Director, IU Human Subjects Office, Office of Research Compliance, Indiana University
Stuart Nicholls, PhD, Senior Clinical Research Associate, Clinical Epidemiology Program, Ottawa Hospital Research Institute
Kelley O’Donoghue, MPH, CIP, Associate Vice President for Human Subject Protection; University of Rochester
Nancy A. Olson, JD, Consultant in Human Research Protections
Brenda Ruotolo, CIP, Executive Director, Human Research Protection Office, Columbia University
Cheryl A, Savini, CIP, Principal, COO, HRP Consulting Group, Inc.
Kimberly Serpico, MEd, CIP, EdD Candidate, Assistant Director of IRB Operations, Harvard School of Public Health
Holly A. Taylor, PhD, MPH, Associate Professor, Berman Institute of Bioethics, Johns Hopkins Bloomberg School of Public Health